Chronic intrapulmonary delivery of a novel small molecule WNT/beta-catenin inhibitor for idiopathic pulmonary fibrosis
Ended Project Grant Awarded Last action
- Award ID
- R41HL142357
- Recipient
-
Iterion Therapeutics Inc. UEI RGK8GNFJGWL1
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,974
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Houston, TX 77021, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $299,974 |
Quick answers
Who received award R41HL142357?
R41HL142357 was awarded to Iterion Therapeutics Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on May 15, 2018.
How much is award R41HL142357 worth?
$299,974 has been obligated on R41HL142357.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award